体外膜肺氧合在重症急性心肌梗死救治中的应用效果:Meta分析

汪雁博; 姜云发; 郝国贞; 谷新顺

doi:10.13201/j.issn.1001-1439.2021.06.007

体外膜肺氧合在重症急性心肌梗死救治中的应用效果:Meta分析

- 河北医科大学第二医院心血管内五科(石家庄,050000)
基金项目:
河北省2019年度医学科学研究课题计划(No:20190523)

详细信息

通讯作者: 谷新顺,E-mail:13930139688@163.com

中图分类号: R542.2

收稿日期: 2020-11-16

修回日期: 2021-03-25

Effects of extracorporeal membrane oxygenation on the treatment in patients with severe myocardial infarction: a Meta analysis

- Department of Cardiology,The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China

More Information

Corresponding author: GU Xinshun, E-mail: 13930139688@163.com

Received Date: 16 November 2020

Revised Date: 25 March 2021

摘要

摘要: 目的:评价体外膜肺氧合(ECMO)在重症急性ST段抬高型心肌梗死(STEMI)救治中的应用效果。方法:检索PubMed、维普、万方和中国知网等数据库中所有已经发表的关于ECMO辅助治疗STEMI并发心源性休克或心脏骤停的观察性研究和对比研究。检索时间为各数据库创建至2019年10月,语言不限。有效性指标包括:成功撤机的比例;住院期间存活率;出院1个月存活率。安全性指标包括:并发症的总发生率;神经系统损伤的发生率;急性肾损伤或行连续肾脏替代疗法(CRRT)的比例;下肢缺血比例;出血、血肿发生率。使用Stata 12.0软件进行分析。结果:最终入选研究17项,共计患者505例。Meta结果显示,应用ECMO辅助治疗后成功撤机比例为0.63[95%CI:(0.45,0.80)],院内生存率为0.53[95%CI:(0.35,0.70)],1个月内生存率为0.63[95%CI:(0.49,0.77)];并发症总体发生率为0.38[95%CI:(0.24,0.52)],神经系统损伤发生率为0.12[95%CI:(0.01,0.20)],急性肾损伤或行CRRT比例为0.41[95%CI:(0.20,0.62)],下肢缺血发生率为0.06[95%CI:(0.02,0.10)],出血和血肿发生率为0.20[95%CI:(0.05,0.35)]。结论:应用ECMO辅助救治并发心源性休克或心脏骤停复苏的重症STEMI具有良好的效果和安全性。
- 体外膜肺氧合 /
- ST段抬高型心肌梗死 /
- 心源性休克 /
- 心脏骤停
Abstract: Objective: To evaluate the effects of extracorporeal membrane oxygenation(ECMO) on the treatment in patients with severe myocardial infarction.Methods: Both foreign and Chinese databases, including PubMed, VIP, Wanfang, and CNKI, were searched to clinical trials that reported the effects of ECMO on the severe ST-segment elevation myocardial infarction(STEMI) from the establishment of each database to October 2019 and the language was not limited. The effective indicators included the rate of successful weaning, the survival rate during hospitalization, and the one-month survival rate after discharge. The safety indicators included the overall incidence of complications, the incidence of nervous system injury, acute kidney injury or continuous renal replacement therapy(CRRT), the rate of lower limb ischemia, and the incidence of hemorrhage and hematoma. Stata 12.0 was used to perform the Meta analysis.Results: Seventeen studies with 505 patients were included. The Meta analysis showed that the rate of successful weaning was 0.63(95%CI: [0.45, 0.80]), the in-hospital survival rate was 0.53(95%CI: [0.35, 0.70 ]), and the one-month survival rate was 0.63(95%CI[0.49, 0.77 ]); The overall incidence of complications was 0.38(95%CI: [0.24, 0.52]), the incidence of neurological injury was 0.12(95%CI:[0.01, 0.20]), and the rate of acute kidney injury or CRRT was 0.41(95%CI:[ 0.20, 0.62]), the incidence of lower limb ischemia was 0.06(95%CI: [0.02, 0.10]), the incidence of hemorrhage and hematoma was 0.20(95%CI:[0.05, 0.35]).Conclusion: ECMO is effective and safe in the treating severe STEMI complicated with cardiogenic shock or cardiac arrest.
- extracorporeal membrane oxygenation /
- ST-segment elevation myocardial infarction /
- cardiac shock /
- cardiac arrest

HTML全文

参考文献(28)

[1]	国家卫生计生委合理用药专家委员会,中国药师协会.急性ST段抬高型心肌梗死溶栓治疗的合理用药指南(第2版)[J].中国医学前沿杂志(电子版),2019,11(1):40-65.
[2]	胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[3]	于洁,张艾婧,黑飞龙.体外膜肺氧合辅助下心肺复苏对成年心脏骤停患者生存影响的meta分析[J].中国体外循环杂志,2015,(3):137-140,145.
[4]	Cheng R,Hachamovitch R,Kittleson M,et al.Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest:a meta-analysis of 1,866 adult patients[J].Ann Thorac Surg,2014,97(2):610-616.
[5]	冯言晓,沈冰晓,王斌.体外膜肺氧合对行PCI的老年急性心肌梗死后心脏骤停患者的疗效分析[J].现代实用医学,2018,30(12):1586-1588.
[6]	刘迎午,李彤,王赟赟,等.体外膜肺氧合辅助下危重急性心肌梗死紧急介入治疗的临床疗效分析[J].中国介入心脏病学杂志,2015,23(12):689-692.
[7]	祖木来提·吐尔逊,哈斯叶提·吐尔逊.体外膜肺氧合联合PCI治疗急性心肌梗死并发心脏骤停的临床疗效[J].中西医结合心脑血管病杂志,2017,15(14):1740-1742.
[8]	鄞松峰,陈太碧,谢惠晗,等.体外膜肺氧合联合急诊PCI抢救急性心肌梗死后心脏骤停的效果[J].中国心血管病研究,2018,16(11):1023-1028.
[9]	黄雷,刘迎午,李彤,等.体外膜肺氧合联合急诊经皮冠状动脉介入治疗抢救急性心肌梗死后心脏骤停的效果[J].中华心血管病杂志,2016,44(7):570-576.
[10]	杨丽娜,肖燕,孙琴.体外膜肺氧合联合急诊经皮冠状动脉介入治疗在急性心肌梗死后心脏停搏中的应用效果[J].实用心脑肺血管病杂志,2017,25(10):88-91.
[11]	蒋崇慧,谢钢,吴丽英,等.体外膜肺氧合与主动脉内气囊反搏治疗急性心肌梗死合并心源性休克的比较研究[J].南方医科大学学报,2009,29(9):1919-1921.
[12]	刘长智,周柱江,卢剑海,等.体外膜肺氧合在急性心肌梗死介入治疗围手术期中的应用[J].中国急救医学,2019,39(4):377-381.
[13]	Lee WC,Fang CY,Chen HC,et al.Associations with 30-day survival following extracorporeal membrane oxygenation in patients with acute ST segment elevation myocardial infarction and profound cardiogenic shock[J].Heart Lung,2016,45(6):532-537.
[14]	Yonezu K,Sakakura K,Watanabe Y,et al.Determinants of survival and favorable neurologic outcomes in ischemic heart disease treated by veno-arterial extracorporeal membrane oxygenation[J].Heart Vessels,2018,33(1):25-32.
[15]	Huang CC,Hsu JC,Wu YW,et al.Implementation of extracorporeal membrane oxygenation before primary percutaneous coronary intervention may improve the survival of patients with ST-segment elevation myocardial infarction and refractory cardiogenic shock[J].Int J Cardiol,2018,269:45-50.
[16]	Sheu JJ,Tsai TH,Lee FY,et al.Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock[J].Crit Care Med,2010,38(9):1810-1817.
[17]	Kim H,Lim SH,Hong J,et al.Efficacy of veno-arterial extracorporeal membrane oxygenation in acute myocardial infarction with cardiogenic shock[J].Resuscitation,2012,83(8):971-975.
[18]	Liu Y,Cheng YT,Chang JC,et al.Extracorporeal membrane oxygenation to support prolonged conventional cardiopulmonary resuscitation in adults with cardiac arrest from acute myocardial infarction at a very low-volume centre[J].Interact Cardiovasc Thorac Surg,2011,12(3):389-393.
[19]	Tsao NW,Shih CM,Yeh JS,et al.Extracorporeal membrane oxygenation-assisted primary percutaneous coronary intervention may improve survival of patients with acute myocardial infarction complicated by profound cardiogenic shock[J].J Crit Care,2012,27(5):530.e1-11.
[20]	Tang GH,Malekan R,Kai M,et al.Peripheral venoarterial extracorporeal membrane oxygenation improves survival in myocardial infarction with cardiogenic shock[J].J Thorac Cardiovasc Surg,2013,145(3):e32-3.
[21]	Pabst D,Foy AJ,Peterson B,et al.Predicting survival in patients treated with extracorporeal membrane oxygenation after myocardial infarction[J].Crit Care Med,2018,46(5):e359-e363.
[22]	林珑,刘冠男,高丽霓,等.经皮冠状动脉介入术后主要不良心脏事件危险因素研究进展[J].临床急诊杂志,2020,21(11):918-922.
[23]	张聪聪.急性心肌梗死患者静脉溶栓、新活素联合治疗后患者心功能与临床症状改善分析[J].临床急诊杂志,2019,20(4):307-311.
[24]	李云曌,吴辉,刘滴,等.急性下壁心肌梗死并严重心源性休克ECMO支持下行急诊PCI 1例及1年随访[J].临床心血管病杂志,2020,36(7):678-680.
[25]	张华东,潘楚云,江意春,等.体外膜肺抢救危重症合并严重心肺功能衰竭的Meta分析[J].临床急诊杂志,2020,21(4):292-295.
[26]	罗明华,关怀敏,解金红,等.体外膜肺氧合联合主动脉球囊反搏支持下经皮冠状动脉介入救治高危冠心病10例总结[J].临床心血管病杂志,2019,35(7):620-624.
[27]	Buerke M,Lemm H,Dietz S,et al.Pathophysiology,diagnosis,and treatment of infarction-related cardiogenic shock[J].Herz,2011,36(2):73-83.
[28]	Vetrovec GW.Hemodynamic support devices for shock and high-risk PCI:when and which one[J].Curr Cardiol Rep,2017,19(10):100.